Community/Retail

The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.

Latest News

Zepbound (tirzepatide) -- Image credit: Douglas | stock.adobe.com
CVS Health Announces It Will Drop Zepbound and Prioritize Coverage of Wegovy

May 14th 2025

The announcement came shortly before updated results from the SURMOUNT-5 clinical trial, which found Zepbound had superior weight-loss effects over Wegovy.

New OTC Option Offers Patients Itch Relief During Summer Activities
New OTC Option Offers Patients Itch Relief During Summer Activities

May 14th 2025

Injection pen for Weight loss medication Zepbound - Tirzepatide is an antidiabetic medication used for the treatment of type 2 diabetes and weight loss. New York, NY, USA - Jan 10 - Image credit: Douglas | stock.adobe.com
Zepbound Shows Superior Weight Loss Compared to Wegovy in SURMOUNT-5 Trial

May 14th 2025

Health care professional speaking with a patient -- Image credit: bongkarn | stock.adobe.com
Engaging in Research and Disseminating Information Are Essential For All Stakeholders, Experts Say

May 14th 2025

More News